1CE0 Stock Overview
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia and Asia.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Vitura Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.062 |
| 52 Week High | AU$0.30 |
| 52 Week Low | AU$0.05 |
| Beta | 0.16 |
| 1 Month Change | -36.08% |
| 3 Month Change | -56.34% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -77.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1CE0 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -1.6% | 0.9% | -1.0% |
| 1Y | n/a | -27.7% | 2.0% |
Return vs Industry: Insufficient data to determine how 1CE0 performed against the German Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 1CE0 performed against the German Market.
Price Volatility
| 1CE0 volatility | |
|---|---|
| 1CE0 Average Weekly Movement | 21.6% |
| Pharmaceuticals Industry Average Movement | 7.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1CE0's share price has been volatile over the past 3 months.
Volatility Over Time: 1CE0's weekly volatility has increased from 15% to 22% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | n/a | vitura.com.au |
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia and Asia. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for medicinal cannabis; CDA Clinics, which provides medicinal cannabis consultations and prescription services; and Cannadoc, a medicinal cannabis clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; and plant-based medications, such as medium chain triglyceride oil and whole flower products under the Adaya brand name.
Vitura Health Limited Fundamentals Summary
| 1CE0 fundamental statistics | |
|---|---|
| Market cap | €44.21m |
| Earnings (TTM) | €5.77m |
| Revenue (TTM) | €73.49m |
7.7x
P/E Ratio0.6x
P/S RatioIs 1CE0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1CE0 income statement (TTM) | |
|---|---|
| Revenue | AU$119.66m |
| Cost of Revenue | AU$81.81m |
| Gross Profit | AU$37.85m |
| Other Expenses | AU$28.45m |
| Earnings | AU$9.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.016 |
| Gross Margin | 31.63% |
| Net Profit Margin | 7.86% |
| Debt/Equity Ratio | 15.9% |
How did 1CE0 perform over the long term?
See historical performance and comparison